|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antioxidant activity of Caesalpinia digyna root显示文摘 | R. Srinivasan M.J.N. Chandrasekar M.J. Nanjan B. Suresh | 2007 | Journal of Ethnopharmacology2007，，2： | 3 |
| 2 | Resveratrol supplemen- tation improves glycemic control in type 2 diabetes melli- tus显示文摘 | Bhatt JK Thomas S Nanjan MJ | 2012 | Nutr Res2012，32，7： | 1 |
| 3 | Antioxidant activity of Caesalpinia digyna root 显示文摘 | Srinivasan R Chandrasekar M J N Nanjan M J | 2007 | J Ethno pharm2007，113，2： | 1 |
| 4 | Antioxidant ac- tivity of Caesalpinia digyna root显示文摘 | Srinivasan R Chandrasekar M J N Nanjan M J | 2007 | J Ethnopharmacol2007，113，6： | 1 |
| 5 | Discovery of lesser known flavones as inhibitors of NF-kappa B signaling in MDA- MB-23t breast cancer cells-A SAR study显示文摘 | Amrutha K Nanjan P Shaji SK | 2014 | Bioorg Med Chem Lett2014，24，19： | 1 |
| 6 | The prevalence of age-related maculopa- thy: the visual impairment project 显示文摘 | Van Newkirk MR Nanjan MB Wang JJ Mitchell P Taylor HR McCarty CA | 2000 | Ophthalmology2000，107，8： | 1 |
| 7 | Antioxi- dant activity of Caesalpinia digyna root显示文摘 | Srinivasan R Chandrasekar MJ Nanjan MJ | 2007 | J Ethnopharma- col2007，113，2： | 1 |
| 8 | Discovery of lesser known flavones as inhibitors of NF-KB signaling in MDA- MB-231 breast cancer cells a SAR study显示文摘 | Amrutha K Nanjan P Shaji SK | 2014 | Bioorg Med Chem Lett2014，24，19： | 1 |
| 9 | Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus显示文摘 | Bhatt JK Thomas S Nanjan MJ | 2012 | Nutr Res2012，32，7： | 1 |
| 10 | Resveratrolsupplementation improves glycemic control in type 2 diabetesmellitus显示文摘 | BHATT J K THOMAS S NANJAN M J | 2012 | Nutr Res2012，32，7： | 1 |
| 11 | Antioxidant activity of Caesalpinia digyna root显示文摘 | SRINIVASAN R CHANDRASEKAR M J N NANJAN M J | 2007 | Journal of Ethnopharmacology2007，113，2： | 1 |
| 12 | Discrete carbon nanotubes increase lead acid battery charge acceptance and performance显示文摘 | Steven W. Swogger Paul Everill D.P. Dubey Nanjan Sugumaran | 2014 | Journal of Power Sources2014，，： | 1 |
| 13 | Resveratrol supple- mentation improves glycemic control in type 2 diabetes mellitus显示文摘 | Bhatt J K Thomas S Nanjan M J | 2012 | Nutr Res2012，32，7： | 1 |
| 14 | Hesveratrol supplemenlationimproves glycemic control in typr 2 diabetes mellitus 显示文摘 | Rhalt JK Thomas S Nanjan MJ | 2012 | NutrRes2012，32，7： | 1 |
| 15 | Health outcome measures for di- abetes mellitus: a review显示文摘 | Bhatt J K Thomas S Nanjan M J | 2012 | Applied Research in Quality of Life2012，7，4： | 1 |
| 16 | Attributable risk estimates for cataract to prioritize medical and public health action显示文摘 | McCarty CA Nanjan MB Taylor HR | 2000 | IOVS2000，41，12： | 1 |
| 17 | Attributable risk estimates for cataract to prioritize medical and public health action显示文摘 | McCarty CA Nanjan MB Taylor HR | 2000 | Invest Ophthalmol Vis Sci2000，41，： | 1 |
| 18 | 一种抗偏头痛复方制剂体外溶出度的比较研究(英文)显示文摘A novel in vitro dissolution profile was developed for formulated drug in combinational form containing naproxen sodium ( NAP) and sumatriptan succinate ( SUMA). This study was performed to understand the dissolution of the drug in the physiological temperature and pH. Dissolution testing was performed using USP 29 type II testing apparatus rotating at 50 r /min,in 900 mL deaerated buffer (pH 1. 2,4. 5 and 6. 8) which was maintained at ( 37 ± 0. 5) ℃. Quantification was performed using a developed and validated high performance liquid chromatographic (HPLC) method. Aceclofenac (ACE) was used as internal standard. SUMA,ACE and NAP w ere eluted at 4. 8,5. 7 and 7. 9 min,respectively. As expected for enteric coated immediate release (IR) tablets,the dissolution of NAP and SUMA was rapid and essentially complete within 2 h using phosphate buffer ( pH 6. 8). The comparison of the dissolution profiles was realized by model independent approach using a difference factor ( f1) ,similarity factor (f2) and dissolution efficiency ( DE). Statistical results show ed the pro-files were similar to the reference and the test products. Hence,this method demonstrated to be adequate for in vitro studies of NAP and SUMA in the combinational dosage form,since there is no official monograph,col-laborating to the official codes. | HIREMATH Vijay Basayya KALIAPERUMAL Krishna BHOJRAJ Suresh NANJAN Mulla Joghee | 2010 | 色谱2010，28，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员